Literature DB >> 461803

Sensitivity of radionuclide brain scan and computed tomography in early detection of viral meningoencephalitis.

E E Kim, F H DeLand, J Montebello.   

Abstract

The sensitivity of radionuclide imaging and computed tomography (CT) was evaluated in 25 patients for early detection of viral meningoencephalitis. Diagnosis was based on clinical evidence, cerebrospinal fluid (CSF) studies, electroencephalography (EEG) and radionuclide imaging. Computed tomography with contrast enhancement was performed within four days after onset of neurological signs or symptoms in 23 patients; no significant findings such as low-absorption abnormalities, mass effect or abnormal enhancement were seen. Radionuclide imaging demonstrated a sensitivity of 90% in the detection of viral meningoencephalitis; the temporal lobe was most commonly involved in patients with herpes encephalitis. Radionuclide imaging should be considered as the first diagnostic procedure in suspected early viral meningoencephalitis.

Entities:  

Mesh:

Year:  1979        PMID: 461803     DOI: 10.1148/132.2.425

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

Review 1.  The role of nuclear procedures in the diagnosis of intracranial disease.

Authors:  U Büll
Journal:  Neurosurg Rev       Date:  1981       Impact factor: 3.042

2.  Multiple cerebral hematoma and viral encephalitis.

Authors:  D Zegers de Beyl; J Noterman; A Martelart; J Flament-Durand; D Baleriaux
Journal:  Neuroradiology       Date:  1980-08       Impact factor: 2.804

3.  Computed tomography in young children with herpes simplex virus encephalitis.

Authors:  T Sugimoto; M Woo; H Okazaki; N Nishida; T Hara; A Yasuhara; M Kasahara; Y Kobayashi
Journal:  Pediatr Radiol       Date:  1985

4.  Utility of the provisional clinical diagnosis as a basis for selection of computed tomographic or radionuclide brain scan.

Authors:  E E Kim; P A Domstad; Y C Choy; F H DeLand
Journal:  J Natl Med Assoc       Date:  1981-09       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.